If New York legislators have questions about the efficacy of the 340B Drug Pricing Program, they should look closely at a ...

At a recent Senate hearing, which refocused attention on the broken 340B Drug Pricing Program, lawmakers were reminded of how far the program has strayed from its original, humanitarian purpose. A ...

Drug companies are at it again. They will not relent in their multiyear campaign to dismantle the 340B Drug Pricing Program. Drug companies are at it again. They will not relent in their multiyear ...